Invesco S&P 500 Quality ETF (SPHQ) earns a reiterated 'buy' rating for its superior quality metrics and strong performance ...

Carrie Underwood is trying not to be blown away by booing "American Idol" fans. The Grammy Award-winning songstress, who is also a judge on the singing reality show, was met with jeers from members of ...

New video released by police shows "American Idol" alum Caleb Flynn in the emotional aftermath of his wife's death.

The Vermont Senate Committee on Education further refined a bill on Friday that would create immigration protocols in Vermont schools.

MercadoLibre (MELI) beats revenue estimates as GMV and payments surge in Brazil and Mexico; explore key Q4 highlights, MELI+ growth, and insights now.

Geographic atrophy (GA) is a severe form of age-related macular degeneration with limited treatment options, affecting millions worldwide. Recent FDA-approved therapies, pegcetacoplan and avacincaptad ...

There are two types of complement 3 glomerulopathy: dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). DDD often begins earlier in life and may progress more quickly. Both are linked to an ...

Proteinuria affects most people with complement 3 glomerulopathy (C3G). Protein in urine is one of the strongest indicators of disease progression. Reducing proteinuria can slow the progression of C3G ...

CTx001, a gene therapy for geographic atrophy, received FDA Fast Track Designation, expediting its development and review process. The Opti-GAIN phase 1/2 trial will assess CTx001's safety, ...

Schistosomula of Schistosoma mansoni became resistant to antibody-dependent complement damage in vitro after pre-incubation with normal human erythrocytes (NHuE) whatever the ABO or Rh blood group.

B&D Fabricators, an Entegra Attachments company, has acquired Leading Edge Attachments Inc. (LEA), a Hubbardston, Massachusetts, supplier of highly unique and patented frost and rock ripping buckets ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...